Infectious Disease Collaboration and Licensing Deals 2020-2026

$4,995.00

Infectious Disease Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2020 to 2026

Publication date
April 2026
Number of pages
850+
Product type
Research report
Report edition
9
SKU
CP2206

 

Infectious Diseases Collaboration and Licensing Deals

Stop guessing. Start benchmarking real deals.

If you’re working on an infectious disease deal, you don’t need more opinions — you need evidence.

This report gives you direct access to 1,700+ real-world partnerships, so you can see exactly how deals are structured, valued, and negotiated across vaccines, antivirals, antibiotics, and emerging technologies.

Free report sample


Know what a “good deal” actually looks like

Without real benchmarks, you’re negotiating in the dark.

With this report, you can:

  • Anchor negotiations with real precedent
    See what companies are actually paying — not what they claim in press releases

  • Benchmark deal terms instantly
    Compare upfronts, milestones, and royalty structures across relevant transactions

  • Avoid overpaying or underselling
    Understand the realistic range for deals at your stage and in your space

  • Challenge counterpart assumptions with data
    Walk into negotiations backed by hard evidence, not guesswork


See how deals are really written — not just announced

Most datasets stop at headlines. That’s not enough.

This report gives you access to actual contracts, so you can see:

  • How rights are allocated

  • What partners commit to (and what they don’t)

  • How payments are structured and triggered

  • Where risks and flexibilities sit

This is the detail that defines deal outcomes — and it’s usually hidden.


Built for teams actively doing deals

Whether you’re licensing, partnering, or evaluating opportunities, this report helps you:

  • Move faster with immediate access to relevant comparables

  • De-risk decisions using real transaction evidence

  • Strengthen internal alignment with credible market data

  • Negotiate from a position of strength


What you get

  • 1,700+ infectious disease deals

  • Financial terms, including royalties where disclosed

  • Fully searchable deal database (by company, therapy, technology, stage)

  • Direct access to SEC-filed agreements

  • 850+ pages of structured deal analysis


The bottom line

If you’re making decisions on incomplete information, you’re taking unnecessary risk.

This report gives you the data, benchmarks, and contract-level insight to structure better deals — and win them.


Request a sample or speak to us about how this can support your current deal work.

Infectious Diseases Collaboration and Licensing Deals provides the reader with the following key benefits:

  • Understand deal trends since 2020
  • Browse infectious diseases collaboration and licensing deals
  • Benchmark analysis – identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in infectious diseases dealmaking

 

2.1. Introduction

2.2. Infectious diseases partnering over the years     

2.3. Infectious diseases partnering by deal type

2.4. Infectious diseases partnering by industry sector

2.5. Infectious diseases partnering by stage of development

2.6. Infectious diseases partnering by technology type

2.7. Infectious diseases partnering by therapeutic indication

 

Chapter 3 – Financial deal terms for infectious diseases partnering

 

3.1. Introduction

3.2. Disclosed financials terms for infectious diseases partnering

3.3. Infectious diseases partnering headline values

3.4. Infectious diseases deal upfront payments

3.5. Infectious diseases deal milestone payments

3.6. Infectious diseases royalty rates

 

Chapter 4 – Leading infectious diseases deals and dealmakers

 

4.1. Introduction

4.2. Most active in infectious diseases partnering

4.3. List of most active dealmakers in infectious diseases    

4.4. Top infectious diseases deals by value

 

Chapter 5 – Infectious diseases contract document directory

                                            

5.1. Introduction

5.2. Infectious diseases partnering deals where contract document available

 

Chapter 6 – Infectious diseases dealmaking by therapeutic target

 

6.1. Introduction

6.2. Deals by infectious diseases therapeutic target

 

Deal directory

 

Deal directory – Infectious diseases deals by company A-Z

Deal directory – Infectious diseases deals by technology type

 

Deal type definitions

 

About Biopharma Research Ltd

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Infectious diseases partnering since 2020

Figure 2: Infectious diseases partnering by deal type since 2020

Figure 3: Infectious diseases partnering by industry sector since 2020

Figure 4: Infectious diseases partnering by stage of development since 2020

Figure 5: Infectious diseases partnering by technology type since 2020

Figure 6: Infectious diseases partnering by indication since 2020

Figure 7: Infectious diseases deals with a headline value

Figure 8: Infectious diseases deals with upfront payment values

Figure 9: Infectious diseases deals with milestone payment

Figure 10: Infectious diseases deals with royalty rates

Figure 11: Active infectious diseases dealmaking activity since 2020

Figure 12: Top infectious diseases deals by value since 2020

Pricing options

  • $4,995: single-user (encrypted file - one user/device)
  • $6,995: multi-user (encrypted file - up to 5 users/devices)
  • $8,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by Evalon.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

3a-diagnostics, 3M, 3rd People’s Hospital of Shenzhen, 4Living Biotech, 7 Hills Pharma, 10X Genomics, 221b Foundation, A2A Pharmaceuticals, Aanika Biosciences, Aardvark Therapeutics, Aarhus University, Abbott Laboratories, Abbvie, AbCellera Biologics, ABEC, Abera Bioscience, Abingdon Health, ABK Remote Drug Testing, ABL Bio, ABL Diagnostics, Ablexis, Abnova, Aboundbio, Absolute Antibody, ABT Innovations, AbVacc, Abveris, Abzena, Academy of Military Medical Sciences (China), AC Bioscience, Accelerated Enrollment Solutions, Accelerate Diagnostics, AcedrA BioPharmaceuticals, Acer Therapeutics, AchilleS Vaccines, Actinium Pharmaceuticals, Active Motif, Acuant, Acumen Diagnostics, Acurx Pharmaceuticals, Ada Health, Adamis Pharmaceuticals, Adaptive Biotechnologies, Adaptive Phage Therapeutics, AdaptVac, Adeptrix, Adjuvance Technologies, ADMA Biologics, Advaccine Biotechnology, Advanced Animal Diagnostics, Advanced Biological Laboratories, Advanced BioScience Laboratories, Advanced Regenerative Manufacturing Institute, Advanz Pharma, Advarra, AdventHealth, Aegea Biotechnologies, Aegis Life, Aerogen, Aerpio Pharmaceuticals, Aethlon Medical, Aetion, Afero, Affinity Biosciences, Affinivax, AffyXell Therapeutics, Africa Centres for Disease Control and Prevention, Africa Medical Supplies Platform, Africa Union, Afrigen Biologics, AFT Pharmaceuticals, AGC Biologics, Age Labs, Agena Bioscience, AgeX Therapeutics, Agile Biodetection, Agilent Technologies, AiCuris, AID Genomics, AIkido Pharma, AIM ImmunoTech, Ainos, AINQA Health, AiPharma Global Holdings, Airway Therapeutics, Ajinomoto Bio-Pharma Services, Akers Biosciences, Akili Interactive Labs, Akribis Systems, Akshaya Bio, Akston Biosciences, Alamar Biosciences, Albany Molecular Research, Albert Einstein College of Medicine, ALBOT Technologies, Alcami, Alderley Analytical, Aldevron, AlgaEnergy, Algernon Pharmaceuticals, Aligos Therapeutics, AlivaMab Discovery Services, Allecra Therapeutics, Alloy Therapeutics, Almirall, Alnylam Pharmaceuticals, Alopexx, Alphamab Biopharmaceuticals, Altamira Pharma, Altamira Therapeutics, Altasciences, Alterity Therapeutics, Altesa Biosciences, Altimmune, Altum Pharmaceuticals, Alveo Technologies, AM-Pharma, American Association for Laboratory Accreditation, American College of Chest Physicians, American Diabetes Association, American Type Culture Collection (ATCC), Amerimmune, AmerisourceBergen, Amerlux, Ametek, Amgen, Amicogen, Amicrobe, Amneal Pharmaceuticals, Amplity Health, Amplyx Pharmaceuticals, AMS, Amyndas Pharmaceuticals, Amyris, AN2 Therapeutics, Analog Devices, AnGes MG, Anixa Biosciences, AnteoTech, Antios Therapeutics, Antisoma Therapeutics, Aphex BioCleanse Systems, Aphios, Appili Therapeutics, Applied Biology, Applied Botanics, Applied DNA Sciences, Applied Pharmaceutical Innovation, Aptar CSP Technologies, Aptar Pharma, Aptitude Medical Systems, Aptorum Group, Aqemia, Aragen Bioscience, Arbor Biosciences, Arbutus, ARCA Biopharma, Arches Research, Arctoris, Arcturus Therapeutics, Ardigen, Ares Genetics, Argonne National Laboratory, Ariadne Genomics, Aridis Pharmaceuticals, ARISE MD Integrative Medicine & Surgery, Arizona State University, Arkansas Children's Research Institute, Arlington Scientific, Armata Pharmaceuticals, Armed Forces Medical Research Institute, Armis Biopharma, Arrevus, Arrowhead Pharmaceuticals, ArtemiLife, Artificial, Asep Medical, Assembly Biosciences, AstraZeneca, Atara Biotherapeutics, Atea Pharmaceuticals, Atomo Diagnostics, Atomwise, Atossa Therapeutics, Atreca, Attana, Attillaps Holdings, ATUM, Auburn University, Audax Medical, Audere, Augmenta, AUM LifeTech, AuraVax Therapeutics, Aurobindo Pharma, Australian Medical Research Institute, Australian Research Council, Austrian Research Promotion Agency, Autonomous Medical Devices Incorporated, Avacta, Avails Medical, Avalon GloboCare, Avalon SteriTech, AvantGen, Aveshka, Avid Bioservices, Avricore Health, Avrok Laboratories, AXIM Biotechnologies, Axiom Real-Time Metrics, Axis Lighting, Azitra, AzurRx BioPharma, Babson Diagnostics, Baebies, Barbara Ann Karmanos Cancer Institute, Barinthus Biotherapeutics, Basilea Pharmaceutica, Batavia Biosciences, Bateman Horne Center, Battelle, Bavarian Nordic, Baylor College of Medicine, BBI Solutions, BC Neuroimmunology, BC Platforms, Beckman Coulter, Becton Dickinson, BeiGene, Beijing Defengrei Biotechnology, Beijing Genomics Institute (BGI), Beijing Minhai Biotechnology, Belfor, Belkin, Berg, Berkeley Lights, Beroni Group, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, BetterLife Pharma, Bharat Biotech, BIA Separations, Big Eye Diagnostics, Bill and Melinda Gates Foundation, BillionToOne, Bilthoven Biologicals, Binex, Bintai Kinden, Binx Health, Bio-Manguinhos/Fiocruz, Bio-Rad Laboratories, Bio-Techne, BioAnalytical Systems, BIOASTER, BioCanna Healthcare, BioCentriq, Biocept, BioComo, Biocom Purchasing Group, Biocon, BioCopy, BioCryst Pharmaceuticals, Biodesix, BioExcel Diagnostics, Biofabri, BioFire Defense, Bioforum, Biogen, BioGX, BioIQ, BioIVT, Biolexis, BioLife Solutions, BioLink Life Sciences, Biological E, BioMatrix Specialty Pharmacy, Biomedical Advanced Research and Development Authority, Biomeme, Biomerica, bioMerieux, BiondVax, BioNet Holding, BioNTech, BioPharma Plasma, Bio Products Laboratory, bioRASI, BioReference Laboratories, Biosenta, BioSig Technologies, BioSure, BioSymetrics, BioSyntagma, Biotechnology Industry Research Assistance Council, BioTek reMEDys, Biotest, BioVaxys, BioVersys, bitBiome, Blacksmith Medicines, Blackstone, Blanver, Blu Biotech, Bluejay Diagnostics, BlueJay Therapeutics, Blue Water Resolute Innovations, Blue Water Vaccines, BlueWillow Biologics, Boca Biolistics, Boehringer Ingelheim, Boeing Company, Bohai Biomedical, Bold Therapeutics, Bonne Santé Group, Booz Allen, Boragen, Bora Pharmaceuticals, Bosch, Boston Immune Technologies and Therapeutics, Boston University, Botanical Solution, Bpifrance, BPL Medical Technologies, BravoVax, BreathTech, Brickell Biotech, Brigham and Women's Hospital, Brii Biosciences, Brio Systems, Bristol-Myers Squibb, Brown University, Bruker, BTG, Bugworks, Burkhan Group, BurstIQ, Butantan Institute, C2Sense, Cadila Pharmaceuticals, California Institute for Biomedical Research, California Institute for Regenerative Medicine, Calithera Biosciences, Calvert Laboratories, Cambridge Consultants, Canabo Medical Clinics, Canadian Hub for Health Intelligence and Innovation in Infectious Diseases, Canadian Institutes of Health Research, Canary Health Technologies, Cancer Research UK, CanSinoBIO, Cantex Pharmaceuticals, Cap Alter Pharma, Capricor Therapeutics, Caprisa, CARB-X, Cardea Bio, Cardiomatics, Care Access Research, CareDx, Caring Cross, CaroGen, Carterra, Cascade Chemistry, Case Western Reserve University, Catabasis Pharmaceuticals, Catalent, Catholic University Leuven, CCT Research, CDR Laboratories, Ceapro, Celanese, Celdara Medical, Cellect Biotechnology, Cellix Bio, CellSafe, Celltrion, Cellvera, Celonic, Celularity, Cenetron, Centene, Center for Breakthrough Medicines, Center for Cancer and Blood Disorders, Centers for Disease Control and Prevention, Centivax, Centogene, Centre for Human Drug Research, Cepheid, Cerba HealthCare, Ceres Nanosciences, Certara, CerTest Biotec, Certify, CGIAR International Livestock Research Institute, Chan Zuckerberg Initiative, Charak Foundation, Charite Universitatsmedizin Berlin, Charles River Laboratories, Chembio Diagnostics, Chengdu Kanghua Biological Products, Children's Hospital of Philadelphia, Chime Biologics, Chimerix, Chimeron Bio, China Resources Pharmaceutical Commercial Group International Trading, Chinese Academy of Sciences, ChromaDex, Chronolife, Chubu University, Chugai Pharmaceutical, CIC Health, Cidara Therapeutics, CimCure, Cincinnati Children’s Hospital Medical Center, Ciox Health, Cipla, Circuit Clinical, CIRION BioPharma Research, Citius Pharmaceuticals, Citranvi Biosciences, City College of New York, City of Corpus Christi, City of Hope, Civica Rx, Clarametyx Biosciences, CLEAR, ClearB Therapeutics, Clear Creek Bio, Cleared4, Cleveland Clinic, Climate Amplified Disease and Epidemics, ClinCapture, Clinical Enterprise, Clinical Reference Laboratory, Clinical Trial and Consulting Services, Clinton Health Access Initiative, Clover Biopharmaceuticals, CLX Health, CN Bio, CNS Pharmaceuticals, Co-Diagnostics, Coalition for Epidemic Preparedness Innovations, Cobra Biologics, Cocrystal Pharma, Codagenix, Codiak BioSciences, Coeptis Therapeutics, CohBar, Colombia Ministry of Health and Social Protection, Colorado State University, Columbia University, Commonwealth of Pennsylvania, Confirm BioSciences, ConserV Bioscience, Contakt World Technologies, ContraFect, Cooper Companies, COPD Foundation, CORAT Therapeutics, Cord Blood Registry, Cornell University, Corpometria Institute, Cosmo Pharmaceuticals, CosmosID, Covar Pharmaceuticals, COVAXX, COVIRIX Medical, CPT Medical, CQuentia, CreaGen Biosciences, Creoptix, Crestone Pharma, Cristalia, Cristal Therapeutics, Croda, Cromos Pharma, CR Pharma, CSIR - Institute of Microbial Technology, CSIRO, CSL, CSL Behring, Cubic, Cue Health, Cumberland Pharmaceuticals, Cupron, Curapath, Curative, Curative Biotechnology, Curebase, CURE Pharmaceutical, Curetis, CureVac, Curia, Curreio, Current Health, CVC, CVD Equipment, CyanVac, Cyclacel Pharmaceuticals, Cyclica, Cyclolab, Cynergy Wellness, Cystic Fibrosis Foundation, Cystron Biotech, Cytiva, CytoAgents, Cytocom, Cytodyn, CytoVale, Cytovance Biologics, CYTOVIA Therapeutics, Cyxone, Daewoong Pharmaceutical, Dalberg, Dalriada Drug Discovery, Dalton Pharma Services, Dante Labs, Dare Bioscience, Dartmouth-Hitchcock Medical Center, Dartmouth College, DaRui Biotech, DATANet Software Development, Datavant, Day Zero Diagnostics, DCN Diagnostics, Debiopharm, deCODE Genetics, Decoy Therapeutics, Defender Pharmaceuticals, Defense Advanced Research Projects Agency, Defense Health Agency (US), Defense Threat Reduction Agency, Dell Medical School, DelSiTech, Denovium, Denso, Department of Defence, Department of Defense, Department of Health and Human Services, Department of Public Health, Department of Veterans Affairs, Dermapharm, Detect-Ion, Deverra Therapeutics, DevsHealth, Dewpoint Therapeutics, DiaSorin, Dicerna Pharmaceuticals, Diffusion Pharmaceuticals, DiNonA, Diomics, DiosCURE Therapeutics, DIOSynVax, DMTC, DoctorsOne Healthcare Systems, Domus Diagnostics, Donnelley Financial Solutions, Door Pharmaceuticals, Dr. Reddy's Laboratories, Drawbridge Health, Drexel University, Drug Farm, Drugs for Neglected Diseases Initiative, DSG, Duality Technologies, Duke-NUS Graduate Medical School Singapore, Duke University, Duke University Medical Center, Dyadic International, Dymax, Dynavax Technologies, DynPort Vaccine Company, E25Bio, Eckerd College, ECO Laboratory, Ecolog International, Edesa Biotech, eGenesis, Eisai, Elanco, Elaris, Elasmogen, ElectroCore, Elektrofi, Eleven Biotherapeutics, Eligo Bioscience, Eli Lilly, Elixirgen, Ellume, Embleema, Emcure Pharmaceuticals, Emergent BioSolutions, Emergex Vaccines, Emery Pharma, Emmes Group, Emory University, Empatica, Empowered Diagnostics, EmVenio Research, Enable Biosciences, ENA Respiratory, Ender Diagnostics, Endo International, Endpoint Health, Enesi Pharma, EnGeneIC, Enlivex, Ennaid Therapeutics, Ennocure MedTech, Enochian Biosciences, Entasis Therapeutics, Entos Pharmaceuticals, Environmental Protection Agency (USA), Enzo Biochem, Enzolytics, Epidemiologic Solutions, EpiPointe, Epivax, EpiVax Therapeutics, Epygen Biotech, Equilab International, Erasmus University Medical Center, ERS Genomics, Essential Pharmaceuticals, Essity, eTheRNA immunotherapies, Ethos Laboratories, Ethris, Eurocine Vaccines, Eurofarma, Eurofins Genomics, Eurofins Scientific, Eurofins Viracor, European Commission, European Innovation Council, European Investment Bank, European Prevention Center, European Union, EVA Pharma, Evaxion Biotech, Everest Medicines, Evergreen Therapeutics, EverlyWell, Eversana, Evofem Biosciences, Evogene, Evotec, EVQLV, Evrys Bio, Evvivax, Ewha Womans University, Exagen Diagnostics, Exavir Therapeutics, ExcellGene, Excision BioTherapeutics, Excivion, ExeVir Bio, Exicure, eXmoor Pharma, Exothera, Experimental Drug Development Centre, ExpreS2ion Biotechnologies, Exscientia, ExThera Medical, Exyte, Eyam Vaccines and Immunotherapeutics, Eyegene, FairJourney Biologics, Fareva Holding, Farmacore Biotechnology, Federal Ministry of Education and Research (BMBF), Feinstein Institute for Medical Research, Felix Biotechnology, Ferozsons Laboratories, FibroGenesis, Finnish Institute for Health and Welfare, Fio, First Wave Bio, FitBit, Flanders Innovation & Entrepreneurship, Fleming Fund, Flightpath Biosciences, Flirtey, Florence, Florica Therapeutics, Florida International University, FlowMetric, FluGen, Fluidigm, Fluxergy, Food and Drug Administration (FDA), ForDoz Pharma, Forge Therapeutics, Fosun Pharmaceutical, Foundation for Innovative New Diagnostics, Foundation for Neglected Disease Research, Fox Chase Chemical Diversity Center, Fraunhofer Institute for Cell Therapy and Immunology, Fraunhofer Institute for Molecular Ecology (IME), Frazier Healthcare Ventures, Frederick National Laboratory For Cancer Research, Fred Hutchinson Cancer Research Center, Frontier Scientific, Fujifilm, FUJIFILM SonoSite, Fujirebio Diagnostics, Fulgent Genetics, Fundacion Medina, Future Pak, FYR Diagnostics, G42 Healthcare, Gaelan Medical, Gamaleya National Center, Gates Medical Research Institute, GAVI Alliance, GBS, GC Pharma, GE Healthcare, GEn1E Lifesciences, Gene Bio Medical, GeneData, Genentech, Generation Biotech, Generex Biotechnology, Genetic Signatures, Genetic Technologies, Genetron Health, GeNeuro, Geneva Foundation, Genevant Sciences, Genexine, Genmab, Gennova Biopharmaceuticals, Genocea Biosciences, Genomadix, Genomma Lab Internacional, GenoScreen, GenScript Biotech, GensKey Medical Technology, George Mason University, George Washington University, GeoSeeq Foundation, GeoVax, German Cancer Research Center, German Center for Infection Research, German Federal Ministry of Education and Research, German Government, Getein Biotech, Gigagen, Gilead Sciences, Ginkgo BioWorks, Gladstone Institutes, Glaukos, Glenmark Pharmaceuticals, Global Access Diagnostics, Global Antibiotic Research and Development Partnership, Global Coalition for Adaptive Research, Global Development Incubator, Global Response Aid, Global Virus Network, Global WholeHealth Partners, GlycoPath, GNP Bioscience, Gnubiotics Sciences, Golden Mountain Partners, Google, Government of Canada, Government of India, Government of South Korea, GPCR Therapeutics, Grand River Aseptic Manufacturing, Gravitas Therapeutics, Gravity Diagnostics, GreenBioAZ, Green Cross LabCell, Greenfield Global, Greenlight Biosciences, Greenwich LifeSciences, Grifols, Gritstone Bio, GS, GSK, GSK Consumer Healthcare, GT Biopharma, GT Molecular, GTP Bioways, Hackensack Meridian Health, Hadassah Medical Center, Hai Kang Life, Hainan Sihuan Pharmaceutical, HAI Solutions, Halberd, Halix, Halodine, Halomine, HaloVax, Halozyme Therapeutics, Hamilton Company, HanaVax, Harbour Biomed, Harro Hofliger, Harvard Medical School, Harvard University, Hasten Biopharmaceutic, HDT Bio, Healion Bio, Healthe, Health Holland, Health Hope Pharma, HealthTrackRx, Healthvana, Health Vector, Heat Biologics, Hebrew University of Jerusalem, Helix, Helocyte, Hememics Biotechnologies, Hemex Health, Hennepin Life Sciences, Henry M. Jackson Foundation, Henry Schein, Hepion Pharmaceuticals, Hetero India, Hetero Labs, HHS Technology Group, HiFiBio, Hikma Pharmaceuticals, HilleVax, Histogen, Hisun BioRay, HitGen, Hoffmann La Roche, Hologic, Hoowaki, Horizon Discovery, Horizon Europe, Hoth Therapeutics, HSS, Humanigen, Hvidovre Hospital, hVIVO, Hybridize Therapeutics, Hyloris Pharmaceuticals, Iaso Therapeutics, iBio, IBM, Icahn School of Medicine at Mount Sinai, Ichor Blood Services, Icon, Iconovo, Icosavax, IDBiologics, IDbyDNA, IdentifySensors Biologics, IDT Biologika, IFC, IGM Biosciences, ILiAD Biotechnologies, Illumina, ImageMover, Imec, Immune Biosolutions, ImmuneCyte Life Sciences, Immune System Regulation, Immune Therapeutics, Immunexpress, ImmunityBio, Immunome, Immunomic Therapeutics, ImmunoPrecise Antibodies, ImmunoScape, ImmunoTek Bio Centers, Immunyx Pharma, Immuron, Imophoron, Imperial College London, ImQuest BioSciences, InBios International, IncellDx, Indiana University, Indian Institute of Science Education and Research, IndyGeneUS AI, Infection Innovation Consortium, Infectious Disease Research Institute (IDRI), Infectolab Americas, Infex Therapeutics, Infinity BiologiX, Inflammatix, InflaRx, Infor, InfoRLife, InfYnity Biomarkers, Inhalon Biopharma, InnoCentive, InnoPharmax, Innosuisse, InnoTech Precision Medicine, Innovare, Innovate UK, Innovation Pharmaceuticals, Innoviva, Innoviva Specialty Therapeutics, Innovo, Inotrem, Inovio, Inovio Pharmaceuticals, Inpixon, Inserm, Inserm Transfert, Insilico Medicine, InSilicoTrials, Insmed Inc, Inspira Pharmaceuticals, Inspira Technologies, Inspirevax, Instem, Institute for Systems Biology, Institute for Transformative Technologies, Institute of Human Virology, Institute of Materia Medica, Institute of Molecular Biology of Paraná (IBMP), Institute of Virology and Immunology, Institut Pasteur, INTACT Solutions, Integral Molecular, Integrated BioTherapeutics, Integrated Computer Solutions, Integumen, Intel, Intellego Technologies, Intermountain Healthcare, International Center for Genetic Engineering and Biotechnology, International Flavors and Fragrances, International Isotopes, International Vaccine Institute (IVI), Intravacc, iNtRON Biotechnology, IntuitiveX, InveniAI, InvisiShield Technologies, Invivyd, InVixa, IONTAS, ipCapital Group, Ipsen, iQ Group, IQVIA, IRBM, IriSys, ISA Pharmaceuticals, IsoPlexis, iSpecimen, Israeli National Authority for Technological Innovation, Israel Institute for Biological Research, ITOCO, Iwatani Group, Jaguar Health, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Agency for Medical Research and Development, Jayne Koskinas Ted Giovanis Foundation for Health and Policy, Jenner Institute, Jhpiego, Jiangsu Carephar Pharmaceutical, Jiangsu Hansoh Pharmaceutical, JN Nova Pharma, John Hopkins University School of Medicines, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, John Snow, Johnson & Johnson, Johnson & Johnson Innovation, Joincare Pharmaceutical, Jolt Health, Jomo Kenyatta University of Agriculture and Technology, Jubilant Hollisterstier, Jubilant Life Sciences, Jubilant Therapeutics, Jumpcode Genomics, Juniper Therapeutics, Junshi Biosciences, Just Biotherapeutics, Kaken Pharmaceutical, Kamada, Kane Biotech, Kansas State University, Kantaro Biosciences, KARE Biosciences, Karius, Karolinska Institute, Karveer Meditech, Karyopharm Therapeutics, Kashiv BioSciences, KBI BioPharma, KBio, Kedrion Biopharma, KELTIC Pharma, Kemin Industries, kENUP Foundation, Kenya Medical Research Institute, Kephera Diagnostics, Kermode Biotechnologies, Keyence, Kiadis Pharma, Kimer Med, Kindred Bio, King Abdullah University for Science and Technology, Kings College London, Kinnear Pharmaceuticals, Kintor, Kleen Bee Labs, Kleo Pharmaceuticals, Kling Biotherapeutics, KM Biologics, Komodo Health, Korea Advanced Institute of Science and Technology, Korrus, KPM Tech, Kukbo, KVK-Tech, Kyowa Hakko Kirin, L1 Systems, L7 Informatics, Laboratoire M2, Laboratorios Farmaceuticos Rovi, Laboratory Corporation of America, Lactiga, La Jolla Institute for Allergy & Immunology, La Jolla Pharmaceutical, Latham BioPharm Group, Laurus Labs, Lawrence Livermore National Laboratory, Lawson Health Research Institute, Laxai Pharma, Leading BioSciences, Leiden University, Leidos, Leinco Technologies, LenioBio, Lenovo, Les Laboratoires Servier, Leukocare, Levitee Labs, Leyden Laboratories, LFB Biotechnologies, LFB Group, LianBio, LifeArc, Lifebit Biotech, LifeLabs Medical Laboratory Services, Ligand Pharmaceuticals, Light Chain Bioscience, LightDeck Therapeutics, Liminal BioSciences, LimmaTech Biologics, Linical, LinkBio, LinKinVax, Lion TCR, Lipigon Pharmaceuticals, LiteVax, Liverpool School of Tropical Medicine, LiveRx Research Group, Livzon Mabpharm, Locus Biosciences, LogicBio Therapeutics, LogicInk, Longhorn Vaccines and Diagnostics, Lonza, Loop Insights, Loreal, Los Angeles County Department of Health Services, Louisiana State University, LSU Health Sciences Center, Lucence, Lucira Health, Lumen Biomedical, Luminare, Luminarie, Luminex, LuminUltra, LumiraDx, Lung Biotechnology, Lupin, Lysando, Lytica Therapeutics, Macleods Pharmaceuticals, Macquarie University, Macromoltek, Macrostruct Holding & Consulting, Magle Chemoswed, Magnetrap, mAIbe, Mainz University Medical Centre, Maitri Health Technologies, Mallinckrodt Pharmaceuticals, Mammoth Biosciences, Manhattan BioSolutions, Mannin Research, MannKind Biopharmaceuticals, Manny Pacquiao Foundation, Mapp Biopharmaceutical, March of Dimes, Marinomed Biotechnologie, Marken, Markforged, Masimo, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mass General Brigham, Mateon Therapeutics, Mathematica, Matinas Biopharma, Matrix Biomed, Matrix Medical Network, MAVIDx, Max-Planck, Max Biopharma, Maxcyte, Maxim Biomedical, Mayo Clinic, MBio Diagnostics, McGill University, McMaster University, MD Biosciences, Meadowlands Diagnostics, Medela, Medexus Pharmaceuticals, MedGene Bioscience, Medicago, Medical Research Futures Fund, Medical Technology Enterprise Consortium, Medical University of Vienna, Medicines Development for Global Health, Medicines Patent Pool Foundation, MediciNova, Medicom, Medigen Vaccine Biologics, Medigus, MediMergent, MedinCell, Medison Pharma, Meditemi, Medivant Healthcare, Medivir, Medlab Clinical, Medline Industries, Medolife Rx, Medytox, Meihua International Medical Technologies, Meitheal Pharmaceuticals, Melinta Therapeutics, Melior Pharmaceuticals, Mellow Hope Bio Chem, MeMed, Memorial Sloan Kettering Cancer Center, Memo Therapeutics, Menarini, Menon Biosensors, Mentholatum Company, Merck and Co, Merck KGaA, Merck Sharpe & Dohme, Meridian Bioscience, Meridian IT, Mesa Biotech, Mesoblast, Metaclipse Therapeutics, MGI Tech, Michigan Medicine, Michigan State University, Micreos, Microbion, Microbiotix, Microbix Biosystems, MicroGEM, Micron Biomedical, Microsoft, Mid-Atlantic BioTherapeutics, miDiagnostics, Mie University, MigVax, MILA International, MiMedx, Mimetas, Ministry of Health (Denmark), Minnesota Health System, Miravo Healthcare, Mirimus, Mithra Pharmaceuticals, Mitsubishi UFJ Capital, MOBILion Systems, Mobility Health, Model Medicines, Moderna, ModeX Therapeutics, Moksha8, Molbio Diagnostics, Molecular Biology Systems, Molecular Loop, Molecular Partners, Molecular Testing Labs, Moleculin Biotech, MolGen, Mologic, Monash University, Monopar Therapeutics, Montefiore Health System, Morehouse School of Medicine, Morgan Stanley, Mosaic ImmunoEngineering, Mount Sinai Health System, Mount Sinai Medical Center, MphRx, MRIGlobal, MSD, MSD Wellcome Trust Hilleman Laboratories, MSN Pharmaceuticals, Multi G, Multiplex Genomics, Mylab Discovery Solutions, Mylan Laboratories, Mymee, Mymetics, NanoDx, Nanomerics, Nanomix, Nanommune, NanoMosaic, Nanopharm, NanoPin Technologies, NanoSpot.ai, NanoViricides, Nanowear, Nant Africa, NantKwest, Nanyang Technological University, Naobios, Napo EU, Napo Pharmaceuticals, Nascent Biotech, National Academy of Sciences, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Cheng Kung University, National Healthcare Services (NHS), National Heart, Lung and Blood Institute, National Institute for Environmental Health Sciences, National Institute for Health Research (NIHR), National Institute of Allergy and Infectious Diseases, National Institute of Biomedical Imaging and Bioengineering, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of General Medical Sciences, National Institute of Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Institute on Deafness and Other Communication Disorders, National Institutes of Biomedical Innovation, Health and Nutrition, National Institutes of Health, National Kidney Registry, National Research Council Canada, National Research Council of Canada, National Science Foundation, Natural Sciences and Engineering Research Council of Canada, Nature Technology, Naval Medical Research Center, Navamedic, Navigo Proteins, NEC, Nepean Blue Mountains Local Health District’s Nepean Hospital, Nestle Health Science, Neurimmune Therapeutics, NeuroLab, Neurophotometrics, NeuroRx, New Day Diagnostics, New England Complex Systems Institute, New York Blood Center, New York City Health and Hospital, New York Presbyterian/Columbia, New Zealand's Foundation for Research, Science and Technology, Nexelis, Neximmune, Next Gen Diagnostics, Next Generation Manufacturing Canada, Nference, Nicoya, NiKang Therapeutics, Nimble Therapeutics, Ninety One, NMI Natural and Medical Sciences Institute, Noachis Terra, Nobelpharma, Nona Biosciences, Norgine, Northeastern University, Northern RNA, NorthStar Medical Radioisotopes, Northway Biotechpharma, Northwestern University, Norwegian Institute of Public Health, Norwegian Research Council, Noscendo, Novartis, Novavax, NoveCite, Novellus Therapeutics, Novogene, Novo Nordisk, Novotech, Now Biopharma, NOWDiagnostics, NRx Pharmaceuticals, NTT Data, Nuance Pharma, NuGenerex Immuno-Oncology, NxGEN MDx, Nykode Therapeutics, NYtor, NYU Langone Medical Center, O2TODAY, Oak Ridge National Laboratory, Octant, Octapharma, Ocugen, ODx, Ohio Department of Development, Ohio State University, Olive Labs, OliX Pharmaceuticals, Ology Bioservices, OmeCare, Omega Diagnostics Group, Omeros, Omniose, OmniPathology, OncoArendi Therapeutics, Oncogenuity, OncoImmune, Oncology Venture, OncoMyx Therapeutics, Oncotelic, Ontochem, OpenAI, Opencell Biomed, Open Philanthropy, Opentrons Labworks, OpGen, Opto-Systems, Oracle, Oragenics, Oramed Pharmaceuticals, OraSure Technologies, Oravax Medical, Orchard Software, Orexo, Organicell Regenerative Medicine, Organon, Orgenesis, Orion Biotechnology, Orna Therapeutics, Orpheus Medical, Ortho-Clinical Diagnostics, OSE Immunotherapeutics, Osivax, Oslo University Hospital, Oswaldo Cruz Foundation (Fiocruz), Otsuka, Owkin, Owlstone Medical, Oxford Biodynamics, Oxford Immunotec, Oxford Nanopore Technologies, Oxgene, Oxitec, OyaGen, Pacific GeneTech, PAI, Paion, Palantir, Panacea Biotech, Pandemic Response Lab, Pangea, Pan Probe Biotech, Pantherna Therapeutics, Paragon Genomics, Paratek Pharmaceuticals, Parexel, Parkway Clinical Laboratories, Partner Therapeutics, Path BioAnalytics, Pathnova Laboratories, Pathogen and Microbiome Institute, PathogenDx, Patient-Centered Outcomes Research Institute, PDS Biotechnology, Pennsylvania State University, PeptiDream, Peptilogics, PerkinElmer Life Sciences, Peter Doherty Institute for Infection and Immunity, Pfizer, Phagelux, Pharm-Olam International, Pharmaceutical Solutions, PharmaCyte Biotech, PharmaJet, Pharmaron, Pharma Science, Pharma Tech Solutions, PharmEnable, Pharmsynthez, PhaseBio Pharmaceuticals, Phase Genomics, PHAXIAM Therapeutics, Phico Therapeutics, Phil, Philips, Phosphorus Genomics, PhysIQ, Pierre Fabre, Pinpoint Science, Piramal, Planet Biotechnology, PlantForm, Plastomics, Plexision, Pluristem Therapeutics, Pluristyx, Pohang University Of Science And Technology, Polichem, Poly Group, PolyPeptide Group, Polyphor, PolyPid, Polyrizon, Population Health Partners, POSCO International, Poseida Therapeutics, PostEra, PPD, Praedicare, PRA Health Sciences, Prairie Hub for Pandemic Preparedness, Precisio Biotix Therapeutics, Precision Biomonitoring, Precision for Medicine, PrecisionLife, Precision NanoSystems, Precision Virologics, Predictmedix, Premas Biotech, Premier Inc, Prenetics, Prenosis, Prestige BioPharma, Prevencio, Prevenio, Primary Bio, Primetime Medical Software, Primordial Genetics, Primrose Bio, Princeton BioMeditech, ProBioGen, Probius, Procare Health, Project to Accelerate New Treatments for Tuberculosis, Prokaryotics, Promega, Prometrika, ProMIS Neurosciences, ProteinLogic, Proteona, ProteoNic, ProterixBio, Proteros biostructures, Providence Therapeutics, PROVIREX Genome Editing Therapies, Provista Diagnostics, Psyche Systems, PT Bio Farma, PT Etana Biotechnologies, Public Health England, Pulmatrix, Pulmonomy, Pulmotect, Pulthera, Purdue Research Foundation, Purdue University, Purna Pharmaceuticals, Purnovate, PWNHealth, Q-linea AB, Q2 Solutions, Q BioMed, QIAGEN, Qilu Pharmaceutical, QMC HealthID, Qnovia, Qpex Biopharma, Qualigen, Quanterix, Quantori, QuantumDx, Quantum Leap Health Care Collaborative, Quartesian Clinical Research, Qu Biologics, Quebec Government, Queen Mary University of London, Queensland University of Technology, Quercis Pharma, Quest Diagnostics, Quidel, Quotient, Quratis, Qure.ai, QureTech Bio, Qurient, R-Pharm, R4D Biotech, Rabian, Radient Technologies, Ragon Institute, RAIsonance, Rapid Dose Therapeutics, Rapid Dx Laboratory, Rational Vaccines, ReAlta Life Sciences, Recce Pharmaceuticals, Recipharm, Redbiotec, RedHill Biopharma, Refana, Rega Institute for Medical Research, Regence, Regeneron Pharmaceuticals, Regnum, ReiThera, Relation Therapeutics, Relay Medical, Remington Pharmaceuticals, Renato Dulbecco Foundation, RenBio, Renegade Bio, Renibus Therapeutics, Rentschler Biotechnologie, Repado, Replicate Bioscience, Repligen, ReproCell, Repurpose.AI, RespiraWorks, resTORbio, Resverlogix, Revelar Biotherapeutics, Revelation Biosciences, reViral, Revive Therapeutics, Reyon Pharmaceuticals, Rhinostics, Richard King Mellon Foundation, Ridgeback Biotherapeutics, Rigel Pharmaceuticals, Rigshospitalet, RIKEN Research Institute, Rising Pharmaceuticals, RNA Disease Diagnostics, Roche, Roche Diagnostics, Rockefeller University, RocketVax, Rokline Health Concepts, Rokote Laboratories, Romanian National Institute of Infectious Diseases, Roncadelle Operations, Roswell Biotechnologies, Royal GD, Royal Philips Electronics, Royaltech Med, RQ Biotechnology, Rubic One Health, Rush University Medical Center, Russian Direct Investment Fund, Rutgers University, Ryerson University, SAB Biotherapeutics, Sabin Vaccine Institute, Saga University, Saiba, Salarius Pharmaceuticals, SalesForce, Samsung Biologics, Samsung Electronics, Sandoz, Sanford Burnham Institute, Sanofi, Sanofi-Pasteur, Sano Genetics, SaNOtize Research and Development, Sanquin Blood Supply Foundation, SaponiQx, Sapphiros, Sarawak Infectious Disease Centre, Sarepta Therapeutics, Sartorius, Sartorius Stedim Biotech, SAS, Satio, SATT Conectus Alsace, SaudiVax, Scandinavian Biopharma, Scanwell Health, Scendea USA, SciClone Pharmaceuticals, Science 37, Science for Life Laboratory, Scilex Pharmaceuticals, Scipher Medicine, SciSafe, Scottish Enterprise, Scripps Research Institute, Scynexis, Seaspring, Seattle Childrens Research Institute, Secarna Pharmaceuticals, Securiport, Seegene, SelectImmune Pharma, Selexis, Sema4, Sen-Jam Pharmaceutical, Senai Cimatec, Sensory Cloud, Seoul National University, Sepset Biosciences, Seqirus, Seraph Research Institute, Seres Therapeutics, SerImmune, Serum Institute of India, SevenScore Pharmaceuticals, SGS Life Science, Shanghai ChemPartner, Shanghai Haini Pharmaceutical, Shanghai Hile Bio-technology, Shanghai Institute of Materia Medica, Shanghai Pharmaceutical, Shanghai Public Health Clinical Centre, Sharps Technology, Sheba Medical Center, Shenzhen Institutes of Advanced Technology, Shenzhen Smoore Technology, Sherlock Biosciences, Shijiazhuang Yuanmai Biotechnology, Shimadzu, Shionogi, Shionogi Pharma, Shyld, Siemens Healthineers, SIGA Technologies, SilcsBio, Simcere Pharmaceuticals, Simon Fraser University, Simulations Plus, Sinclair Research, Singlomics Biopharmaceuticals, Sino Biological, Sinotek-Advocates International Industry Development, Sinovac Biotech, SINTX Technologies, SiO2 Medical Products, Sirnaomics, Sirona Biochem, Sixty Degrees Pharmaceuticals, SK Bioscience, Skoll Foundation, Skymount Medical, SkyWater Technology, smartbax, Smart Immune, SmartPharm Therapeutics, SmartShape Design, Smiths Medical, SMS Pharmaceuticals, Societal CDMO, SoftBank Robotics Group, Soligenix, SOM Biotech, Sona Nanotech, Sonata Scientific, Sonde Health, SOPHiA Genetics, Sorrento Therapeutics, SourceBio International, Source Molecular, Southern Research Institute, Southwest Research Institute, Spartan Medical, SpeeDx, Spero Therapeutics, Spicona, SpikImm, SpyBiotech, SQI Diagnostics, SRI International, St. Jude Children's Research Hospital, Stablepharma, Staidson (Beijing) BioPharmaceuticals, Stanford University, Stanford University School of Medicine, State of New Jersey, Statera Biopharma, Stavros Niarchos Foundation, St Elizabeth Healthcare, Stellenbosch University, Stemedica Cell Technologies, SteriLumen, St Georges University of London, Stony Brook University, Strategic Innovation Fund, Strategic Vaccines, Strides Arcolab, Strides Pharma Science, St Thomas University, Suanfarma, Sumaya Biotech, Summit Biosciences, Sun Pharmaceutical, Sun Pharma Global, Sunshine Biopharma, Sun Yat-sen University, Surfacide, Suzhou Porton Advanced Solutions, Swift Biosciences, Symphogen, Symvivo, Synairgen, Synbal, Synertex, Synexa Life Sciences, Syngene International, Syntegra, Syntekabio, Syracuse University, T2 Biosystems, Tabuk Pharmaceutical, Tabula Rasa HealthCare, Taiba, TaiGen Biotechnology, TaiMed, Takara Bio USA, Takeda Pharmaceutical, Takis Biotech, Talem Therapeutics, Talis Biomedical, Tangen Biosciences, Targeted Pharmaceutical, Tauriga Sciences, TAXIS Pharmaceuticals, TB Alliance, TC BioPharm, Tecan, Tech Innovation Global, Techmer PM, Technogenetics, TechnoVax, Tektronix Component Solutions, Telcon RF Pharmaceuticals, Temple University, Tempus, Tencent Holdings, TenNor Therapeutics, Tetherex Pharmaceuticals, Tetra Bio-Pharma, Teva Pharmaceutical Industries, Tevogen Bio, Texas A&M University, Texas Biomedical Research Institute, Texas Lung Injury Institute, TFF Pharmaceuticals, The Binding Site, The International AIDS Vaccine Initiative, The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center, The Native Antigen Company, Therapeutic Solutions International, Therapyx, Therma Bright, Thermo Fisher Scientific, Thomas Jefferson University, Thylacine Biotherapeutics, Tianjin CanSino Biotechnology, Tianjin University, Tiba Biotech, TidalHealth, TLC BioSciences, Todos Medical, Tokai University, TOMI Environmental Solutions, TONIX Pharmaceuticals, Toray, Torrent Pharmaceuticals, Total Testing Solutions, Totient, Touchlight, Toyohashi University of Technology, Toyota Tsusho, Trans-Hit Bio, Translate Bio, Translational Genomics Research Institute, Transtoxbio, Trellis Bioscience, Trevena, TrialSpark, Tried & Tested, TriLink BioTechnologies, Trinomab Biotech, True Diagnostics, TSB Therapeutics, TScan Therapeutics, Tsinghua University, TTP Group, Tufts Medical Center, Tufts University, Tulane University, Turn Therapeutics, Twist Bioscience, U-Diagnostics, U.K. Department for International Development, Ubiquitome, Ubirch, UgenTec, UK Government, Ultromics, UMass Memorial Medical Center, Undisclosed Company, UNION Therapeutics, UniQuest, Unison Medicines, UNITAID, United BioPharma, UnitedHealth, United Therapeutics, Univercells, University Gottingen, University Health Network, University Hospital Bonn, University Hospital Heidelberg, University Hospital Jena, University of Aberdeen, University of Adelaide, University of Alabama, University of Alabama at Birmingham, University of Alberta, University of Amsterdam, University of Antwerp, University of Arizona, University of Arkansas, University of Birmingham, University of Bonn, University of British Columbia, University of Buffalo, University of Calgary, University of California, Davis, University of California, San Diego, University of California, San Diego (UCSD) School of Medicine, University of California Berkeley, University of California San Francisco, University of Campinas, University of Chicago, University of Dundee, University of Edinburgh, University of Florida, University of Georgia, University of Hawaii, University of Hong Kong, University of Houston, University of Illinois, University of Illinois at Chicago, University of Lausanne, University of Leuven, University of Liverpool, University of Louisville, University of Maryland, University of Maryland, Baltimore County, University of Maryland Baltimore, University of Maryland School of Medicine, University of Massachusetts Medical School, University of Melbourne, University of Miami, University of Michigan, University of Minnesota, University of Nebraska, University of New South Wales, University of Nottingham, University of Oklahoma, University of Ottawa, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Pittsburgh Medical Center, University of Queensland, University of Saskatchewan, University of Strathclyde, University of Sydney, University of Tennessee, University of Texas, University of Texas Health Science Center at Houston, University of Texas Health Science Center at Tyler, University of Texas Medical Branch, University of Toronto, University of Tubingen, University of Vermont, University of Virginia, University of Washington, University of Waterloo, University of Wisconsin-Madison, University of Zagreb, University of Zaragoza, University of Zurich, UPS Supply Chain Services, US Air Force, US Army, US Army Medical Research and Material Command, US Army Medical Research Institute of Infectious Diseases, US Biologic, US Department of Agriculture, US Government, US Navy, Utrecht University, Vaccitech, Vaccizone, Valneva, Valo Therapeutics, Vanda Pharmaceuticals, Vanderbilt University, Variation Biotechnologies, Vault Health, VaxAlta, Vaxart, Vaxess Technologies, Vaxil BioTherapeutics, Vaxinano, Vaxine, VaxNewMo, VaxThera, Vaxxas, Vayyar Imaging, VBI Vaccines, Vectans Pharma, Vector Institute, Vectura, Vedanta Biosciences, Veeva Systems, Vela Diagnostics, Velox Biosystems, VenatoRx, Veracyte, Vera Therapeutics, Veravas, Verily, Veristat, Vernalis, Verndari, Versatope Therapeutics, Versiti Blood Research Institute, Vetophage, Vetoquinol, ViaClean Technologies, Viatris, VIB, Vibrent Health, Vicore Pharma, Victoria University, Vidscrip, ViiV Healthcare, Vinbiocare Biotechnology, Vinnova, Vipergen, ViraCor Laboratories, ViralClear Pharmaceuticals, Viravaxx, Vir Biotechnology, Virex Health, Virginia Catalyst, Virginia Commonwealth University, Virion Therapeutics, Virios Therapeutics, Viroclinics Biosciences, Virpax Pharmaceuticals, VirTrial, Virusight Diagnostics, Visby Medical, VitalHub, VitriVax, Vituity, Vivacelle Bio, Vivera Pharmaceuticals, Vizient, Voltron Therapeutics, Vortran Medical, Vyv, Wageningen University, Walter and Eliza Hall Institute, Washington University in St Louis, Watchmaker Genomics, Weill Cornell Medical College, Wellcome Trust, Westlake Pharma, Westport Bio, Willow Biosciences, Wipro, Wistar Institute, World Health Organization, WorldIPI, WPD Pharmaceuticals, WuXi Biologics, Wyss Institute, X-chem, Xanadu Bio, Xavier University of Louisiana, Xcelerate Solutions, Xediton Pharmaceuticals, Xencor, Xerox, Xiamen Amoytop Biotech, Xortx Therapeutics, XPhyto Therapeutics, XPRIZE Pandemic Alliance, XWell, Y2X Life Sciences, Yale Cancer Center, Yale School of Medicine, Yale University, Yunnan Walvax Biotech, ZabBio, Zalgen Labs, ZebiAI Therapeutics, Zelluna Immunotherapy, ZeptoMetrix, Zhejiang Jiuzhou Pharmaceutical, Zhifei Lvzhu Biopharmaceutical, Zivo Bioscience, Zoetis, Zoic Labs, Zumutor Biologics, Zydus Cadila, Zymeworks, Zymo Research, ZYUS Life Sciences

About Current Partnering

A definitive, evidence-based approach to dealmaking intelligence

Current Partnering is the industry-leading provider of pharmaceutical and biotech dealmaking intelligence, delivering a clear, structured, and evidence-based view of how partnerships are designed, negotiated, and executed in practice.

Our reports combine comprehensive deal coverage, structured data analysis, and contract-level insight, enabling a deeper understanding of how financial terms, rights, and responsibilities are defined across real-world transactions.

All reports are updated every six months, ensuring users have access to the latest deal activity, trends, and market developments.


Our methodology

Built on a continuously updated proprietary database

All analysis is underpinned by Current Agreements, our proprietary deals and alliances database which is updated daily by our analysts as new transactions are announced globally.

Deal records are continuously reviewed and enriched as additional information becomes available, ensuring accuracy, completeness, and relevance.


Comprehensive and verifiable data sourcing

Deal data is sourced from publicly available industry disclosures, including:

  • Company press releases and announcements
  • SEC filings and equivalent regulatory disclosures
  • Company and investor presentations
  • Conference materials and company websites

All sources are captured and referenced, enabling full transparency and user verification.


Broad coverage across deal types and structures

Current Partnering provides comprehensive coverage across a wide range of deal types, including but not limited to:

  • Licensing and co-development
  • Research and collaborative R&D
  • Manufacturing, supply, and distribution
  • Commercialisation and co-promotion
  • Equity investments, joint ventures, and asset transactions
  • Options, royalties, and financing agreements

This breadth ensures a complete view of how partnerships are structured across the life sciences sector.


Structured, standardised analysis

Every deal is analysed using a consistent framework, capturing (where disclosed):

  • Financial terms — including upfront payments, milestones, and royalties
  • Rights allocation — development, manufacturing, and commercialization responsibilities
  • Deal structure — exclusivity, territorial scope, and agreement type
  • Contractual provisions — clauses defining risk, control, and value-sharing

Each deal record is fully categorised, including data fields such as:

  • Therapy area and technology type
  • Stage of development
  • Asset type and deal components
  • Geographic scope and exclusivity
  • Source documentation, including press releases and SEC filings

Financial normalisation for comparability

All financial values are standardised to USD using the exchange rate at the time of deal announcement, enabling consistent comparison of deal terms across geographies.


Contract-level insight

Where available, reports include direct access to underlying agreement documents, providing visibility into how deals are constructed in practice.

This enables users to understand:

  • How financial mechanisms are defined and triggered
  • How responsibilities are operationalised between parties
  • How flexibility, risk, and control are allocated within agreements

Designed for real-world application

Current Partnering reports are built to support business-critical decision-making across the life sciences ecosystem, including:

  • Pharmaceutical and biotech companies — benchmarking deals, structuring transactions, and supporting licensing strategy
  • Investment firms and venture capital — assessing deal benchmarks, valuation expectations, and partner behaviour
  • Advisory, legal, and consulting firms — supporting client engagements with real-world precedent and contract-level insight

Common use cases include:

  • Benchmarking comparable transactions
  • Supporting valuation and deal structuring
  • Preparing for negotiations
  • Evaluating potential partners
  • Informing internal strategy with real-world evidence

A trusted industry reference

With a long track record in the sector, Current Partnering is relied upon by leading pharmaceutical companies, emerging biotechs, investors, and advisory firms as a trusted source of dealmaking intelligence.

By combining proprietary data, rigorous methodology, and contract-level insight, our reports provide a reliable and authoritative foundation for understanding how deals are structured, negotiated, and valued.